How have EBN shares performed in 2024?

Epicore BioNetworks' stock was trading at C$1.29 at the beginning of the year. Since then, EBN stock has increased by 0.0% and is now trading at C$1.29. View the best growth stocks for 2024 here .

What other stocks do shareholders of Epicore BioNetworks own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Epicore BioNetworks investors own include Cross Timbers Royalty Trust (CRT) , InfraCap MLP ETF (AMZA) , Alliance Resource Partners (ARLP) , Brigham Minerals (MNRL) , Arbor Realty Trust (ABR) , Advanced Emissions Solutions (ADES) , Archer-Daniels-Midland (ADM) , AGNC Investment (AGNC) and AMC Entertainment (AMC) .

How do I buy shares of Epicore BioNetworks?

Shares of EBN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:EBN

Epicore BioNetworks (EBN) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Free EBN Stock Alerts

C$1.29

-0.01 (-0.77%)

(As of 12/14/2017)

Compare

Today's Range: C$1.29
▼
C$1.29
50-Day Range: C$1.29
▼
C$1.29
52-Week Range: C$0.54
▼
C$1.32

Volume: 54,778 shs
Average Volume: 29,654 shs
Market Capitalization: C$34.03 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Epicore BioNetworks alerts:

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

About Epicore BioNetworks

Epicore BioNetworks Inc. (Epicore) develops, manufactures and markets specialty biotechnology, biochemical and nutrition products. Epicore specialty biochemical products are mixtures of specialty organic, inorganic and biochemical ingredients that facilitate microbe and plant growth. Some Epicore products (such as its EPIZYM-AGP COMPLETE) stimulate algae growth, an important property in shrimp and bivalve hatcheries that grow algae as animal food. Some of its products (such as EPIZYM-BGM) support microbe growth for customers who grow-up an Epicore microbial ecosystem at their location. Some Epicore biochemical products stimulate plant growth to increase plant yield and environmental stress resistance. The third Epicore product group is specialty animal feeds. These products are an extension of its microbial growth media expertise and are primarily used in aquaculture. Its EPIFEED -LHF and EPILITE liquid shrimp larval feeds are tools to help hatchery managers raise postlarval shrimp.

EBN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EBN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive EBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epicore BioNetworks and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Manufacturing
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Current Symbol: CVE:EBN
CUSIP: N/A
CIK: N/A
Web: epicorebionetworks.com
Phone: +1-609-2679118
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 26,380,000
Free Float: N/A
Market Cap: C$34.03 million
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

William P. Long
President, Chief Executive Officer, Chief Operating Officer, Director
Russell Rosenzweig
Chief Financial Officer, Company Secretary
Robert Stephen Poulton
Non-Executive Chairman of the Board
Donald R. Siemens
Director
Stefan Zaphiriou Zarifi
Director
Alan C. Savage
Independent Director

Key Competitors

View All Competitors

EBN Stock Analysis - Frequently Asked Questions

How have EBN shares performed in 2024?: Epicore BioNetworks' stock was trading at C$1.29 at the beginning of the year. Since then, EBN stock has increased by 0.0% and is now trading at C$1.29.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Epicore BioNetworks own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Epicore BioNetworks investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC).
How do I buy shares of Epicore BioNetworks?: Shares of EBN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:EBN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial